Three cases with a wild-type KRAS mutation in the adenoma component housed a KRAS mutation in the carcinoma component, and two cases with codon 12 mutation in the residual adenoma component demonstrated a wild-type KRAS mutation in the carcinoma component. Here, KRAS is linked to carcinoma.